Healthcare & Life Sciences
Omega Therapeutics
United Statesomegatherapeutics.com
Omega Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
activeseries-c-plus
series-c-plus
Stage
2017
Founded
1
Investors
About Omega Therapeutics
Omega Therapeutics is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Omega Therapeutics develops gene control therapies using programmable epigenome editing technologies to treat diseases by modifying gene expression patterns.
Explore Omega Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.